Background and Aims HCC is a leading cause of cancer‐related deaths globally with poor
outcome and limited therapeutic options. Although the myelocytomatosis (MYC) oncogene is …

Background Protein arginine methylation has emerged a pivotal role in cancer progression.
However, the role of protein arginine methyltransferase 3 (PRMT3) in hepatocellular …

Protein arginine methyltransferase 1 (PRMT1) is a key regulator of hepatic immune
responses. Recently, we reported that PRMT1 regulates the tumor immune response in …

Hepatocellular carcinoma (HCC) is a major type of liver cancer caused by the hepatitis B
and C viruses, alcohol and exposure to aflatoxin. For HCC treatment, anticancer drugs have …

Protein arginine methyltransferases (PRMT) catalyze protein arginine methylation and play
an important role in many biological processes. Aberrant PRMT expression in tumor cells …

The prognosis of advanced hepatocellular carcinoma (HCC) is dismal. Novel molecular
targets for diagnosis and therapy is urgently required. This study evaluated expression and …

Background Protein arginine methyltransferase 5 (PRMT5), a type II PRMT, is highly
expressed in some tumors, but its role in hepatocellular carcinoma (HCC) is still unknown …

Protein arginine methyltransferases (PRMT) are a widely expressed class of enzymes
responsible for catalyzing arginine methylation on numerous protein substrates. Among …

Recurrent chromosomal aberrations have led to the discovery of oncogenes or tumour
suppressors involved in carcinogenesis. Here we characterized an oncogenic long …

Protein arginine methyltransferases (PRMTs) have been implicated in the development of
various cancers. PRMT2, a member of the type I PRMT family, is overexpressed in multiple …